投资建议 - 对Health Catalyst (NASDAQ: HCAT) 给出买入评级 认为公司转型进展顺利 [1] - 新推出的Ignite平台是主要增长催化剂 将在未来持续推动增长 [1] 投资策略 - 采用自下而上的分析方法 深入研究公司基本面优劣势 [1] - 投资期限为中长期 关注具有扎实基本面、可持续竞争优势和增长潜力的公司 [1] 分析师背景 - 投资方法结合长期投资与短期做空策略以发掘超额收益机会 [1]

In April 2025, Completed Recent Share Repurchase Program of 6.95 Million Shares YOKNEAM, Israel, April 28, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: U.S. GAAP Results (U.S. dollars in thousands, except for per share data) | | Q1 2025 | Q1 2024 | | --- | --- | --- | | Revenues | $77,874 | $80,284 | | Gross ...